159 related articles for article (PubMed ID: 22820807)
1. Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda.
Sendagire I; Cobelens F; Kambugu A; Konde-Lule J; van der Loeff MS
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e33-9. PubMed ID: 22820807
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.
Kesselring S; Osborne C; Bever A; Salters K; Cui Z; Chia J; Moore DM; Parashar S; Kaida A; Samji H; Duddy J; Gabler K; Howard T; Nash D; McCandless LC; Patterson TL; Corneil T; Montaner JSG; Hogg RS
AIDS Care; 2019 Jul; 31(7):885-892. PubMed ID: 30466303
[TBL] [Abstract][Full Text] [Related]
3. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
[TBL] [Abstract][Full Text] [Related]
5. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
7. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men.
Liu Y; Ruan Y; Vermund SH; Osborn CY; Wu P; Jia Y; Shao Y; Qian HZ
BMC Infect Dis; 2015 Dec; 15():570. PubMed ID: 26714889
[TBL] [Abstract][Full Text] [Related]
8. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
[TBL] [Abstract][Full Text] [Related]
9. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
[TBL] [Abstract][Full Text] [Related]
10. Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.
Castelnuovo B; Musaazi J; Musomba R; Ratanshi RP; Kiragga AN
BMC Infect Dis; 2015 Jul; 15():252. PubMed ID: 26126616
[TBL] [Abstract][Full Text] [Related]
11. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
[TBL] [Abstract][Full Text] [Related]
12. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
[TBL] [Abstract][Full Text] [Related]
13. Predictors of delayed Anti-Retroviral Therapy initiation among adults referred for HIV treatment in Uganda: a cross-sectional study.
Kiyingi M; Nankabirwa JI; Sekaggya-Wiltshire C; Nangendo J; Kiweewa JM; Katahoire AR; Semitala FC
BMC Health Serv Res; 2023 Jan; 23(1):40. PubMed ID: 36647104
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
[TBL] [Abstract][Full Text] [Related]
15. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
16. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
Sun J; Liu L; Shen J; Chen P; Lu H
BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
[TBL] [Abstract][Full Text] [Related]
17. Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda.
Muhamadi L; Tumwesigye NM; Kadobera D; Marrone G; Wabwire-Mangen F; Pariyo G; Peterson S; Ekström AM
Pan Afr Med J; 2011; 8():40. PubMed ID: 22121448
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional comparative study of risky sexual behaviours among HIV-infected persons initiated and waiting to start antiretroviral therapy in rural Rakai, Uganda.
Nakiganda LJ; Nakigozi G; Kagaayi J; Nalugoda F; Serwadda D; Sewankambo N; Gray R; Ndyanabo A; Muwanika R; Asamoah BO
BMJ Open; 2017 Sep; 7(9):e016954. PubMed ID: 28893749
[TBL] [Abstract][Full Text] [Related]
20. Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda.
Semeere AS; Lwanga I; Sempa J; Parikh S; Nakasujja N; Cumming R; Kambugu A; Mayanja-Kizza H
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):382-9. PubMed ID: 25171733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
